微软公司携手华盛顿大学、弗雷德·哈钦森癌症研究中心等合作机构，近日公布了一项颠覆乳腺癌筛查模式的临床研究成果。这项发表在《Radiology》医学期刊的研究表明，其开发的人工智能系统不仅显著提升乳腺癌筛查的检测精准度，更大幅减少不必要的患者召回和活体组织检查。
该AI模型创新性地实现了高灵敏度下的精准度突破，在确保放射科医师诊断信心的同时，有效缩短了影像解读时间。值得注意的是，该系统同时适用于快速增强乳腺MRI检查与完整诊断流程，有望将扫描耗时压缩近30%。
研究团队已向科学界开源代码与方法论框架，标志着医疗AI领域透明化协作的重要进展。若后续在更大规模、更多样化的临床群体中得到验证，这项技术或将重塑早期乳腺癌筛查标准。目前该模型正加速推进商业化进程，医疗影像诊断市场格局或将迎来变革。
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.